Skip to content

NEIVATECH Virtual Reality-based System for Amblyopia

Prospective Pilot Study of the NEIVATECH Virtual Reality-based System to Improve Visual Function in Children with Amblyopia

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04819386
Acronym
NEIVATECH
Enrollment
20
Registered
2021-03-29
Start date
2022-07-01
Completion date
2024-09-30
Last updated
2024-10-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Amblyopia

Keywords

Amblyopic children, Perceptual learning, Dichoptic training, Virtual reality, Gamification

Brief summary

The NEIVATECH system has been designed to provide binocular vision training to 7-15 year old amblyopic children by discriminating Gabor patches presented with different contrast to each eye as a perceptual learning task.

Detailed description

Due to the global impact of amblyopia, there is a medical and social need, and at the same time, a clear market niche, for the design and development of new therapies that can improve recurrence rates and non-compliance with conventional treatments. In this sense, the aim of this single-arm, multicentre, prospective pilot study is to examine the safety, acceptability and clinical efficacy of a novel Virtual Reality-based system designed to provide binocular vision training to 7-15 year old amblyopic children complementing the concepts of perceptual learning and dichoptic training with a gamification approach.

Interventions

OTHERActive vision therapy sessions with the NEIVATECH Virtual Reality-based system

The active visual therapy sessions with the NEIVATECH Virtual Reality-based system will be 18 in total, will have an average duration of half an hour and will be distributed over a month as follows: 5 sessions in the first two weeks after enrollment (Monday to Friday) and 4 sessions in the next two weeks (Monday to Thursday).

Sponsors

University of Alicante
CollaboratorOTHER
University of Valladolid
CollaboratorOTHER
Hospital Clínico Universitario de Valladolid
CollaboratorOTHER
Increase-Tech
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
7 Years to 15 Years
Healthy volunteers
No

Inclusion criteria

* Children aged between 7 and 15 years. * VA in the amblyopic eye \< 0.1 logMAR units. * Interocular difference in VA ≥ 1 logMAR line. * Interocular difference in espherical equivalent ≥ 1 D. * Interpupillary distance (IPD) between 60.7 and 73.5 mm. * Use of best refractive correction for at least 2 months prior to inclusion. * Lack of response or therapeutic adherence to conventional occlusion therapy. * Willingness to attend all the active vision therapy sessions and/or visits of the study. * No history of previous treatment for amblyopia other than optimal refractive correction for at least 2 months prior to inclusion.

Exclusion criteria

* Active eye disease. * Previous ocular surgery. * BCVA in the amblyopic eye of ≥ 0.70 logMAR. * Presence of cognitive impairment or neurological or psychiatric disorders. * Presence of irregular cornea due to astigmatism or ectatic corneal disease.

Design outcomes

Primary

MeasureTime frameDescription
Change in distance best-corrected visual acuity (BCVA)Baseline - 1 monthETDRS, logMAR scale, maximum -0.3 (best) and minimum 1.20 (worse)

Secondary

MeasureTime frameDescription
Change in near BCVABaseline - 1 monthETDRS, logMAR scale, maximum -0.3 (best) and minimum 1.20 (worse)
Change in photopic contrast sensitivity function (CSF)Baseline - 1 monthCSV-1000 test for spatial frequencies of 3, 6, 12 and 18 cycles/degree

Other

MeasureTime frameDescription
Change in fusional vergenceBaseline - 1 monthMagnitude of base-out and base-in prisms needed to obtain diplopia while the patient is looking at a distance and near (40 cm) stimulus
Change in refraction under cycloplegiaBaseline - 1 monthMagnitude of sphere and cylinder (diopters), orientation of axis of astigmatism (degrees)
Change in near point of convergenceBaseline - 1 monthClosest distance in cm in reference to the nasal root of the patient at which the subject is able to maintain single vision
Change in accommodative facilityBaseline - 1 monthNumber of changes performed achieving an optimum focus using a spherical flipper of +-2.00 D while the patient is looking at a near optotype (VA 0,63)
Change in stereopsisBaseline - 1 monthMagnitude of stereoacuity (seconds of arc)
Change in binocular visionBaseline - 1 monthWorth's four dot test and Four prism dioptre reflex text

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 17, 2026